Koers MJardin Group, Inc. Canadian Securities Exchange
Aandelen
MJAR
CA60689X1096
Farmaceutische producten
Omzet 2019 | 26,7 mln. 36,49 mln. 24,97 mln. | Omzet 2020 | 11,44 mln. 15,63 mln. 10,7 mln. | Marktkapitalisatie | 3,41 mln. 4,66 mln. 3,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -267 mln. -365 mln. -250 mln. | Nettowinst (verlies) 2020 | -34 mln. -46,47 mln. -31,8 mln. | EV/omzet 2019 | 5,55 x |
Nettoschuld 2019 | 134 mln. 183 mln. 125 mln. | Nettoschuld 2020 | 164 mln. 224 mln. 153 mln. | EV/omzet 2020 | 14,6 x |
K/w-verhouding 2019 |
-0,06
x | K/w-verhouding 2020 |
-0,1
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 92,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 26-05-21 |
Edward Jonasson
DFI | Director of Finance/CFO | 55 | 01-11-19 |
Patrick Witcher
BRD | Director/Board Member | - | 07-05-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 26-05-21 |
Blair Jordan
BRD | Director/Board Member | 55 | 26-05-21 |
James Lowe
BRD | Director/Board Member | - | 06-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
+0,09% | 1,65 mld. | |
-7,89% | 1,68 mld. | |
-12,97% | 1,53 mld. | |
+33,40% | 1,38 mld. |